The first interesting in-vitro interventional study was performed by Evangelopoulos et al. [71], who analyzed neurotrophin receptor surface expression of neuroblastoma cells and exposed these cells to recombinant NGF to assess cell line survival and proliferation [71]. The gene discussed is NGF; the disease is neuroblastoma.